2001New England Journal of MedicineRequires access

Use of Misoprostol in Pregnancy

Ralph W. Hale, Stanley Zinberg

Open publisher page 34 citations

Abstract

The article by Goldberg et al. in this issue of the Journal reviews the evidence supporting the use of misoprostol in women at various stages of pregnancy.1 The authors identified more than 200 studies involving more than 16,000 women who received misoprostol and conclude that “misoprostol is one of the most important medications in obstetrical practice.”1 The product-information enclosure approved by the Food and Drug Administration (FDA) states that misoprostol is indicated for the prevention of gastric ulcers caused by nonsteroidal antiinflammatory drugs in patients who are at high risk for these ulcers.2 The contraindications include pregnancy, because of misoprostol's . . .

About this research paper

What this paper is about

The article by Goldberg et al. in this issue of the Journal reviews the evidence supporting the use of misoprostol in women at various stages of pregnancy.1 The authors identified more than 200 studies involving more than 16,000 women who received misoprostol and conclude that “misoprostol is one of the most important medications in obstetrical practice.”1 The product-information enclosure approved by the Food and Drug Administration (FDA) states that misoprostol is indicated for the prevention of gastric ulcers caused by nonsteroidal antiinflammatory drugs in patients who are at high risk for these ulcers.2 The contraindications include pregnancy, because of misoprostol's . . .

Why it matters

OpenAlex reports 34 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The article by Goldberg et al. in this issue of the Journal reviews the evidence supporting the use of misoprostol in women at various stages of pregnancy.1 The authors identified more than 200 studies involving more than 16,000 women who received misoprostol and conclude that “misoprostol is one of the most important medications in obstetrical practice.”1 The product-information enclosure approved by the Food and Drug Administration (FDA) states that misoprostol is indicated for the prevention of gastric ulcers caused by nonsteroidal antiinflammatory drugs in patients who are at high risk for these ulcers.2 The contraindications include pregnancy, because of misoprostol's . . .

Key concepts: Misoprostol, Medicine, Pregnancy, Obstetrics, Food and drug administration, Products of conception, Drug, Gynecology

Related papers

Back to paper searchBrowse research topicsOriginal source
Use of Misoprostol in Pregnancy — Research Paper | ScholarLens